Episurf: First Episealer® surgery in Malaysia scheduled

Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Malaysia with the knee implant Episealer® has been scheduled.

"We are committed to developing our commercial strategy in the APAC region, we have started slowly, with a few market registrations of which Malaysia has been one, so it is exciting to get started here. Over the coming months we will invest in accelerating our commercial strategy for the APAC region. We appreciate the support we receive from our local partners and this partnership will get stronger as we grow," comments Stephen Caswell, Head of Sales OUS, Episurf Medical.  

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com